| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.048 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |